The Role of BDNF in Epilepsy and Other Diseases of the Mature Nervous System

  • Devin K. Binder
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 548)


The neurotrophin brain-derived neurotrophic factor (BDNF) is ubiquitous in the central nervous system (CNS) throughout life. In addition to trophic effects on target neurons, BDNF appears to be part of a general mechanism for activity-dependent modification of synapses in the developing and adult nervous system. Thus, diseases of abnormal trophic support (such as neurodegenerative diseases) and diseases of abnormal excitability (such as epilepsy and central pain sensitization) can be related in some cases to abnormal BDNF signaling. For example, various studies have shown that BDNF is upregulated in areas implicated in epileptogenesis, and interference with BDNF signal transduction inhibits the development of the epileptic state. Further study of the cellular and molecular mechanisms by which BDNF influences cell survival and excitability will likely provide novel concepts and targets for the treatment of diverse CNS diseases.


Nerve Growth Factor Temporal Lobe Epilepsy Mossy Fiber BDNF Expression BDNF mRNA 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barde Y-A, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982; 1: 549–553.PubMedGoogle Scholar
  2. 2.
    Levi-Montalcini R, Hamburger V. Selective growth-stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool 1951; 116: 321–361.PubMedCrossRefGoogle Scholar
  3. 3.
    Maisonpierre PC, Le Beau MM, Espinosa R et al Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 1991; 10: 558–68.PubMedCrossRefGoogle Scholar
  4. 4.
    Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Op Neurobiol 2001; 11: 272–280.PubMedCrossRefGoogle Scholar
  5. 5.
    Barbacid M. The trk family of neurotrophin receptors. J Neurobiol 1994; 25: 1386–403.PubMedCrossRefGoogle Scholar
  6. 6.
    Schlessinger J, Ulrich A. Growth factor signaling by receptor tyrosine kinases. Neuron 1992; 9: 381–391.CrossRefGoogle Scholar
  7. 7.
    Guiton M, Gunn-Moore FJ, Stitt TN et al. Identification of in vivo brain-derived neurotrophic factor-stimulated autophosphorylation sites on the trkB receptor tyrosine kinase by site-directed mutagenesis. J Biol Chem 1994; 269: 30370–30377.PubMedGoogle Scholar
  8. 8.
    Heumann R Neurotrophin signalling. Curr Op Neurobiol 1994; 4: 668–679.PubMedCrossRefGoogle Scholar
  9. 9.
    Kaplan DR, Stephens RM. Neurotrophin signal transduction by the trk receptor. J Neurobiol 1994; 25: 1404–1417.PubMedCrossRefGoogle Scholar
  10. 10.
    Middlemas DS, Meisenhelder J, Hunter T. Identification of trkB autophosphorylation sites and evidence that phospholipase C-gammal is a substrate of the trkB receptor. J Biol Chem 1994; 269: 5458–5466.PubMedGoogle Scholar
  11. 11.
    Segal RA, Greenberg ME. Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci 1996; 19: 463–489.PubMedCrossRefGoogle Scholar
  12. 12.
    Urfer R, Tsoulfas P, O’Connell L et al. An immunoglobulin-like domain determines the specificity of neurotrophin receptors. EMBO J 1995; 14: 2795–2805.PubMedGoogle Scholar
  13. 13.
    Chao MV, Hempstead BL. p75 and trk: a two-receptor system. Trends Neurosci 1995; 18: 321–326.PubMedCrossRefGoogle Scholar
  14. 14.
    Roux P, Barker P. Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 2002; 67: 203.PubMedCrossRefGoogle Scholar
  15. 15.
    Dechant G, Barde YA. The neurotrophin receptor p75NTR: novel functions and implications for diseases of the nervous system. Nat Neurosci 2002; 5: 1131–1136.PubMedCrossRefGoogle Scholar
  16. 16.
    Inagaki N, Thoenen H, Lindholm D. TrkA tyrosine residues involved in NGF-induced neunte outgrowth of PC12 cells. Eur J Neurosci 1995; 7: 1125–1133.PubMedCrossRefGoogle Scholar
  17. 17.
    Grimes ML, Zhou J, Beattie EC et al. Endocytosis of activated trkA: evidence that nerve growth factor induces formation of signaling endosomes. J Neurosci 1996; 16: 7950–7964.PubMedGoogle Scholar
  18. 18.
    Von Bartheld CS, Williams R, Lefcort F et al. Retrograde transport of neurotrophins from the eye to the brain in chick embryos: roles of the p75NTR and trkB receptors. J Neurosci 1996; 16: 2995–3008.Google Scholar
  19. 19.
    Bhattacharyya A, Watson FL, Bradlee TA et al. Trk receptors function as rapid retrograde signal carriers in the adult nervous system. J Neurosci 1997; 17: 7007–7016.PubMedGoogle Scholar
  20. 20.
    Riccio A, Pierchala BA, Ciarallo CL et al. An NGF-trkA-mediated retrograde signal to transcription factor CREB in sympathetic neurons. Science 1997; 277: 1097–1100.PubMedCrossRefGoogle Scholar
  21. 21.
    Senger DL, Campenot RB. Rapid retrograde tyrosine phosphorylation of trkA and other proteins in rat sympathetic neurons in compartmented cultures. J Cell Biol 1997; 138: 411–421.PubMedCrossRefGoogle Scholar
  22. 22.
    Maclnnis BL, Campenot RB. Retrograde support of neuronal survival without retrograde transport of nerve growth factor. Science 2002; 295: 1536–9.CrossRefGoogle Scholar
  23. 23.
    Barker PA, Hussain NK, McPherson PS. Retrograde signaling by the neurotrophins follows a well-worn trk. Trends Neurosci 2002; 25: 379–381.PubMedCrossRefGoogle Scholar
  24. 24.
    Conner JM, Lauterborn JC, Yan Q et al. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS-evidence for anterograde axonal transport. J Neurosci 1997; 17: 2295–2313.PubMedGoogle Scholar
  25. 25.
    Bengzon J, Kokaia Z, Ernfors P et al. Regulation of neurotrophin and trkA, trkB and trkC tyrosine kinase receptor messenger RNA expression in kindling. Neuroscience 1993; 53: 433–46.PubMedCrossRefGoogle Scholar
  26. 26.
    Fryer RH, Kaplan DR, Feinstein SC et al. Developmental and mature expression of full-length and truncated trkB receptors in the rat forebrain. J Comp Neurol 1996; 374: 21–40.PubMedCrossRefGoogle Scholar
  27. 27.
    Lindvall O, Kokaia Z, Bengzon J et al. Neurotrophins and brain insults. Trends Neurosci 1994; 17: 490–496.PubMedCrossRefGoogle Scholar
  28. 28.
    Yan Q, Rosenfeld RD, Matheson CR et al. Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system. Neuroscience 1997; 78: 431–448.PubMedCrossRefGoogle Scholar
  29. 29.
    Von Bartheld CS, Byers MR, Williams R et al. Anterograde transport of neurotrophins and axodendritic transfer in the developing visual system. Nature 1996; 379: 830–833.CrossRefGoogle Scholar
  30. 30.
    Altar CA, Cai N, Bliven T et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 1997; 389: 856–860.PubMedCrossRefGoogle Scholar
  31. 31.
    Zhou X-F, Rush RA. Endogenous brain-derived neurotrophic factor is anterogradely transported in primary sensory neurons. Neuroscience 1996; 74: 945–951.PubMedGoogle Scholar
  32. 32.
    Fawcett JP, Bamji SX, Causing CG et al. Functional evidence that BDNF is an anterograde neuronal trophic factor in the CNS. J Neurosci 1998; 18: 2808–2821.PubMedGoogle Scholar
  33. 33.
    Tonra JR, Curtis R, Wong V et al. Axotomy upregulates the anterograde transport and expression of brain-derived neurotrophic factor by sensory neurons. J Neurosci 1998; 18: 4374–4383.PubMedGoogle Scholar
  34. 34.
    Kohara K, Kitamura A, Morishima M et al. Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons. Science 2001; 291: 2419–2423.PubMedCrossRefGoogle Scholar
  35. 35.
    Nawa H, Takei N. BDNF as an anterophin; a novel neurotrophic relationship between brain neurons. Trends Neurosci 2001; 24: 683–684.PubMedCrossRefGoogle Scholar
  36. 36.
    Smith MA, Zhang LX, Lyons WE et al. Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers. Neuroreport 1997; 8: 1829–1834.PubMedCrossRefGoogle Scholar
  37. 37.
    Fawcett JP, Aloyz R, McLean JH et al. Detection of brain-derived neurotrophic factor in a vesicular fraction of brain synaptosomes. J Biol Chem 1997; 272: 8837–40.PubMedCrossRefGoogle Scholar
  38. 38.
    Blöchl A, Thoenen H. Characterization of nerve growth factor (NGF) release from hippocampal neurons: evidence for a constitutive and an unconventional sodium-dependent regulated pathway. Eur J Neurosci 1995; 7: 1220–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Blöchl A, Thoenen H. Localization of cellular storage compartments and sites of constitutive and activity-dependent release of nerve growth factor (NGF) in primary cultures of hippocampal neurons. Mol Cell Neurosci 1996; 7: 173–90.PubMedCrossRefGoogle Scholar
  40. 40.
    Goodman LJ, Valverde J, Lim F et al. Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons. Mol Cell Neurosci 1996; 7: 222–238.PubMedCrossRefGoogle Scholar
  41. 41.
    Griesbeck O, Canossa M, Campana G et al. Are there differences between the secretion characteristics of NGF and BDNF? Implications for the modulatory role of neurotrophins in activity-dependent neuronal plasticity. Microsc Res Tech 1999; 45: 262–75.PubMedCrossRefGoogle Scholar
  42. 42.
    Canossa M, Gartner A, Campana G et al. Regulated secretion of neurotrophins by metabotropic glutamate group I (mGluRI) and Trk receptor activation is mediated via phospholipase C signalling pathways. EMBO J 2001; 20: 1640–50.PubMedCrossRefGoogle Scholar
  43. 43.
    Purves D, Lichtman JW. Principles of neural development. Sunderland, MA: Sinauer, 1985.Google Scholar
  44. 44.
    Barde YA. Trophic factors and neuronal survival. Neuron 1989; 2: 1525–1534.PubMedCrossRefGoogle Scholar
  45. 45.
    Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24: 677–736.PubMedCrossRefGoogle Scholar
  46. 46.
    Jones KR, Farinas I, Backus C et al. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 1994; 76: 989–99.PubMedCrossRefGoogle Scholar
  47. 47.
    Tucker KL, Meyer M, Barde YA. Neurotrophins are required for nerve growth during development. Nat Neurosci 2001; 4: 29–37.PubMedCrossRefGoogle Scholar
  48. 48.
    Carroll P, Lewin GR, Koltzenburg M et al. A role for BDNF in mechanosensation. Nat Neurosci 1998; 1: 42–6.PubMedCrossRefGoogle Scholar
  49. 49.
    Acheson A, Conover JC, Fandl JP et al. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 1995; 374: 450–3.PubMedCrossRefGoogle Scholar
  50. 50.
    Lotto RB, Asavaritikrai P, Vali L et al. Target-derived neurotrophic factors regulate the death of developing forebrain neurons after a change in their trophic requirements. J Neurosci 2001; 21: 3904–10.PubMedGoogle Scholar
  51. 51.
    Xu B, Zang K, Ruff NL et al. Cortical degeneration in the absence of neurotrophin signaling: dendritic retraction and neuronal loss after removal of the receptor trkB. Neuron 2000; 26: 233–45.PubMedCrossRefGoogle Scholar
  52. 52.
    Patel MN, McNamara JO. Selective enhancement of axonal branching of cultured dentate gyrus neurons by neurotrophic factors. Neuroscience 1995; 69: 763–70.PubMedCrossRefGoogle Scholar
  53. 53.
    Lowenstein DH, Arsenault L. The effects of growth factors on the survival and differentiation of cultured dentate gyrus neurons. J Neurosci 1996; 16: 1759–1769.PubMedGoogle Scholar
  54. 54.
    McAllister AK, Lo DC, Katz LC. Neurotrophins regulate dendritic growth in developing visual cortex. Neuron 1995; 15: 791–803.PubMedCrossRefGoogle Scholar
  55. 55.
    McAllister AK, Katz LC, Lo DC. Neurotrophin regulation of cortical dendritic growth requires activity. Neuron 1996; 17: 1057–1064.PubMedCrossRefGoogle Scholar
  56. 56.
    McAllister AK, Katz LC, Lo DC. Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth. Neuron 1997; 18: 767–78.PubMedCrossRefGoogle Scholar
  57. 57.
    Cohen-Cory S, Fraser SE. Effects of brain-derived neurotrophic factor on optic axon branching and remodelling in vivo. Nature 1995; 378: 192–196.PubMedCrossRefGoogle Scholar
  58. 58.
    Maffei L, Berardi N, Domenici L et al. Nerve growth factor (NGF) prevents the shift in ocular dominance distribution of visual cortical neurons in monocularly deprived rats. J Neurosci 1992; 12: 4651–62.PubMedGoogle Scholar
  59. 59.
    Cabelli RJ, Hohn A, Shatz CJ. Inhibition of ocular dominance column formation by infusion of NT-4/5 or BDNF. Science 1995; 267: 1662–6.PubMedCrossRefGoogle Scholar
  60. 60.
    Cabelli RJ, Shelton DL, Segal RA et al. Blockade of endogenous ligands of trkB inhibits formation of ocular dominance columns. Neuron 1997; 19: 63–76.PubMedCrossRefGoogle Scholar
  61. 61.
    Holtzman DM, Lowenstein DH. Selective inhibition of axon outgrowth by antibodies to NGF in a model of temporal lobe epilepsy. J Neurosci 1995; 15: 7062–7070.PubMedGoogle Scholar
  62. 62.
    Castrén E, Zafra F, Thoenen H et al. Light regulates expression of brain-derived neurotrophic factor mRNA in rat visual cortex. Proc Natl Acad Sci USA 1992; 89: 9444–8.PubMedCrossRefGoogle Scholar
  63. 63.
    Castrén E, Thoenen H, Lindholm D. Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus. Neuroscience 1995; 64: 71–80.PubMedCrossRefGoogle Scholar
  64. 64.
    Rocamora N, Welker E, Pascual M et al. Upregulation of BDNF mRNA expression in the barrel cortex of adult mice after sensory stimulation. J Neurosci 1996; 16: 4411–4419.PubMedGoogle Scholar
  65. 65.
    Li XC, Jarvis ED, Alvarez-Borda B et al. A relationship between behavior, neurotrophin expression, and new neuron survival. Proc Natl Acad Sci USA 2000; 97: 8584–9.PubMedCrossRefGoogle Scholar
  66. 66.
    Patterson SL, Grover LM, Schwartzkroin PA et al. Neurotrophin expression in rat hippocampal slices: a stimulus paradigm inducing LTP in CA1 evokes increases in BDNF and NT-3 mRNAs. Neuron 1992; 9: 1081–8.PubMedCrossRefGoogle Scholar
  67. 67.
    Castrén E, Pitkanen M, Sirvio J et al. The induction of LTP increases BDNF and NGF mRNA but decreases NT-3 mRNA in the dentate gyrus. Neuroreport 1993; 4: 895–8.PubMedCrossRefGoogle Scholar
  68. 68.
    Bramham CR, Southard T, Sarvey JM et al. Unilateral LTP triggers bilateral increases in hippocampal neurotrophin and trk receptor mRNA expression in behaving rats: evidence for interhemispheric communication. J Comp Neurol 1996; 368: 371–382.PubMedCrossRefGoogle Scholar
  69. 69.
    Neeper SA, Gomez-Pinilla F, Choi J et al. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 1996; 726: 49–56.PubMedCrossRefGoogle Scholar
  70. 70.
    Oliff HS, Berchtold NC, Isackson P et al. Exercise-induced regulation of brain-derived neurotrophic factor (BDNF) transcripts in the rat hippocampus. Brain Res Mol Brain Res 1998; 61: 147–53.PubMedCrossRefGoogle Scholar
  71. 71.
    Frost DO. BDNF/trkB signaling in the developmental sculpting of visual connections. Prog Brain Res 2001; 134: 35–49.PubMedCrossRefGoogle Scholar
  72. 72.
    Thoenen H. Neurotrophins and neuronal plasticity. Science 1995; 270: 593–8.PubMedCrossRefGoogle Scholar
  73. 73.
    Schuman EM. Neurotrophin regulation of synaptic transmission. Curr Opin Neurobiol 1999; 9: 105–9.PubMedCrossRefGoogle Scholar
  74. 74.
    Thoenen H. Neurotrophins and activity-dependent plasticity. Prog Brain Res 2000; 128: 183–91.PubMedCrossRefGoogle Scholar
  75. 75.
    Poo MM. Neurotrophins as synaptic modulators. Nat Rev Neurosci 2001; 2: 24–32.PubMedCrossRefGoogle Scholar
  76. 76.
    Lohof AM, Ip NY, Poo MM. Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature 1993; 363: 350–3.PubMedCrossRefGoogle Scholar
  77. 77.
    Knipper M, Leung LS, Zhao D et al. Short-term modulation of glutamatergic synapses in adult rat hippocampus by NGF. Neuroreport 1994; 5: 2433–6.PubMedCrossRefGoogle Scholar
  78. 78.
    Lessmann V, Gottmann K, Heumann R. BDNF and NT-4/5 enhance glutamatergic synaptic transmission in cultured hippocampal neurones. Neuroreport 1994; 6: 21–5.PubMedCrossRefGoogle Scholar
  79. 79.
    Kang H, Schuman EM. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 1995; 267: 1658–62.PubMedCrossRefGoogle Scholar
  80. 80.
    Stoop R, Poo MM. Synaptic modulation by neurotrophic factors: differential and synergistic effects of brain-derived neurotrophic factor and ciliary neurotrophic factor. J Neurosci 1996; 16: 3256–64.PubMedGoogle Scholar
  81. 81.
    Carmignoto G, Pizzorusso T, Tia S et al. Brain-derived neurotrophic factor and nerve growth factor potentiate excitatory synaptic transmission in the rat visual cortex. J Physiol 1997; 498: 153–164.PubMedGoogle Scholar
  82. 82.
    Wang X, Poo M. Potentiation of developing synapses by postsynaptic release of neurotrophin-4. Neuron 1997; 19: 825–835.PubMedCrossRefGoogle Scholar
  83. 83.
    Messaoudi E, Bardsen K, Srebro B et al. Acute intrahippocampal infusion of BDNF induces lasting potentiation of synaptic transmission in the rat dentate gyrus. J Neurophysiol 1998; 79: 496–499.PubMedGoogle Scholar
  84. 84.
    Tanaka T, Saito H, Matsuki N. Inhibition of GABAA synaptic responses by brain-derived neurotrophic factor (BDNF) in rat hippocampus. J Neurosci 1997; 17: 2959–2966.PubMedGoogle Scholar
  85. 85.
    Frerking M, Malenka RC, Nicoll RA. Brain-derived neurotrophic factor (BDNF) modulates inhibitory, but not excitatory, transmission in the CA1 region of the hippocampus. J Neurophysiol 1998; 80: 3383–6.PubMedGoogle Scholar
  86. 86.
    Figurov A, Pozzo-Miller LD, Olafsson P et al. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 1996; 381: 706–9.PubMedCrossRefGoogle Scholar
  87. 87.
    Akaneya Y, Tsumoto T, Kinoshita S et al. Brain-derived neurotrophic factor enhances long-term potentiation in rat visual cortex. J Neurosci 1997; 17: 6707–6716.PubMedGoogle Scholar
  88. 88.
    Korte M, Carroll P, Wolf E et al. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 1995; 92: 8856–60.PubMedCrossRefGoogle Scholar
  89. 89.
    Korte M, Griesbeck O, Gravel C et al. Virus-mediated gene transfer into hippocampal CAl region restores long-term potentiation in brain-derived neurotrophic factor mutant mice. Proc Natl Acad Sci USA 1996; 93: 12547–52.PubMedCrossRefGoogle Scholar
  90. 90.
    Patterson SL, Abel T, Deuel TA et al. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 1996; 16: 1137–45.PubMedCrossRefGoogle Scholar
  91. 91.
    Scharfman HE. Hyperexcitability in combined entorhinal/hippocampal slices of adult rat after exposure to brain-derived neurotrophic factor. J Neurophysiol 1997; 78: 1082–1095.PubMedGoogle Scholar
  92. 92.
    Takei N, Sasaoka K, Inoue K et al. Brain-derived neurotrophic factor increases the stimulation-evoked release of glutamate and the levels of exocytosis-associated proteins in cultured cortical neurons from embryonic rats. J Neurochem 1997; 68: 370–5.PubMedCrossRefGoogle Scholar
  93. 93.
    Suen P-C, Wu K, Levine ES et al. Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-D-aspartate receptor subunit 1. Proc Natl Acad Sci USA 1997; 94: 8191–8195.PubMedCrossRefGoogle Scholar
  94. 94.
    Berninger B, Garcia DE, Inagaki N et al. BDNF and NT-3 induce intracellular Cat’ elevation in hippocampal neurones. Neuroreport 1993; 4: 1303–6.PubMedCrossRefGoogle Scholar
  95. 95.
    Levine ES, Dreyfus CF, Black IB et al. Differential effects of NGF and BDNF on voltage-gated calcium currents in embryonic basal forebrain neurons. J Neurosci 1995; 15: 3084–91.PubMedGoogle Scholar
  96. 96.
    Kafitz KW, Rose CR, Thoenen H et al. Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 1999; 401: 918–21.PubMedCrossRefGoogle Scholar
  97. 97.
    Marty S, Berzaghi MP, Berninger B. Neurotrophins and activity-dependent plasticity of cortical interneurons. Trends Neurosci 1997; 20: 198–202.PubMedCrossRefGoogle Scholar
  98. 98.
    Xu B, Gottschalk W, Chow A et al. The role of brain-derived neurotrophic factor receptors in the mature hippocampus: Modulation of long-term potentiation through a presynaptic mechanism involving TrkB. J Neurosci 2000; 20: 6888–97.PubMedGoogle Scholar
  99. 99.
    Manabe T. Does BDNF have pre or postsynaptic targets? Science 2002; 295: 1651–3.PubMedCrossRefGoogle Scholar
  100. 100.
    Kovalchuk Y, Hanse E, Kafitz KW et al. Postsynaptic induction of BDNF-mediated long-term potentiation. Science 2002; 295: 1729–34.PubMedCrossRefGoogle Scholar
  101. 101.
    Hall J, Thomas KL, Everitt BJ. Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat Neurosci 2000; 3: 533–535.PubMedCrossRefGoogle Scholar
  102. 102.
    Ishibashi H, Hihara S, Takahashi M et al. Tool-use learning induces BDNF expression in a selective portion of monkey anterior parietal cortex. Brain Res Mol Brain Res 2002; 102: 110.CrossRefGoogle Scholar
  103. 103.
    Linnarsson S, Bjorklund A, Ernfors P. Learning deficit in BDNF mutant mice. Eur J Neurosci 1997; 9: 2581–2587.PubMedCrossRefGoogle Scholar
  104. 104.
    Ma YL, Wang HL, Wu HC et al. Brain-derived neurotrophic factor antisense oligonucleotide impairs memory retention and inhibits long-term potentiation in rats. Neuroscience 1998; 82: 957–967.PubMedCrossRefGoogle Scholar
  105. 105.
    Minichiello L, Korte M, Wolfer D et al. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 1999; 24: 401–14.PubMedCrossRefGoogle Scholar
  106. 106.
    Hauser WA, Kurland LT. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 1975; 16: 1–66.PubMedCrossRefGoogle Scholar
  107. 107.
    Morgan JI, Curran T. Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and fun. Annu Rev Neurosci 1991; 14: 421–451.PubMedCrossRefGoogle Scholar
  108. 108.
    Kiessling M, Gass P. Immediate early gene expression in experimental epilepsy. Brain Pathol 1993; 3: 381–393.PubMedCrossRefGoogle Scholar
  109. 109.
    Gall C, Lauterborn J, Bundman M et al. Seizures and the regulation of neurotrophic factor and neuropeptide gene expression in brain. Epilepsy Res-Suppl 1991; 4: 225–45.PubMedGoogle Scholar
  110. 110.
    Meberg PJ, Gall CM, Routtenberg A. Induction of F 1/GAP-43 gene expression in hippocampal granule cells after seizures. Brain Res Mol Brain Res 1993; 17: 295–9.PubMedCrossRefGoogle Scholar
  111. 111.
    Qian Z, Gilbert M, Colicos MA et al. Tissue plasminogen activator is induced as an immediate-early gene during seizure, kindling, and long-term potentiation. Nature 1993; 361: 453–457.PubMedCrossRefGoogle Scholar
  112. 112.
    Gall CM, Isackson PJ. Limbic seizures increase neuronal production of messenger RNA for nerve growth factor. Science 1989; 245: 758–61.PubMedCrossRefGoogle Scholar
  113. 113.
    Gall CM. Seizure-induced changes in neurotrophin expression: Implications for epilepsy. Exp Neurol 1993; 124: 150–66.PubMedCrossRefGoogle Scholar
  114. 114.
    Binder DK, Gall CM, Croll SD et al. BDNF and epilepsy: Too much of a good thing? Trends Neurosci 2001; 24: 47–53.PubMedCrossRefGoogle Scholar
  115. 115.
    Ernfors P, Bengzon J, Kokaia Z et al. Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron 1991; 7: 165–76.PubMedCrossRefGoogle Scholar
  116. 116.
    Isackson PJ, Huntsman MM, Murray KD et al. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF. Neuron 1991; 6: 937–48.PubMedCrossRefGoogle Scholar
  117. 117.
    Dugich-Djordjevic MM, Tocco G, Lapchak PA et al. Regionally specific and rapid increases in brain-derived neurotrophic factor messenger RNA in the adult rat brain following seizures induced by systemic administration of kainic acid. Neuroscience 1992; 47: 303–15.PubMedCrossRefGoogle Scholar
  118. 118.
    Dugich-Djordjevic MM, Tocco G, Willoughby DA et al. BDNF mRNA expression in the developing rat brain following kainic acid-induced seizure activity. Neuron 1992; 8: 1127–38.PubMedCrossRefGoogle Scholar
  119. 119.
    Humpel C, Wetmore C, Olson L. Regulation of brain-derived neurotrophic factor messenger RNA and protein at the cellular level in pentylenetetrazol-induced epileptic seizures. Neuroscience 1993; 53: 909–18.PubMedCrossRefGoogle Scholar
  120. 120.
    Merlio JP, Ernfors P, Kokaia Z et al. Increased production of the TrkB protein tyrosine kinase receptor after brain insults. Neuron 1993; 10: 151–64.PubMedCrossRefGoogle Scholar
  121. 121.
    Schmidt-Kastner R, Olson L. Decrease of neurotrophin-3 mRNA in adult rat hippocampus after pilocarpine seizures. Exp Neurol 1995; 136: 199–204.PubMedCrossRefGoogle Scholar
  122. 122.
    Schmidt-Kastner R, Humpel C, Wetmore C et al. Cellular hybridization for BDNF, trkB, and NGF mRNAs and BDNF-immunoreactivity in rat forebrain after pilocarpine-induced status epilepticus. Exp Brain Res 1996; 107: 331–47.PubMedCrossRefGoogle Scholar
  123. 123.
    Mudo G, Jiang XH, Timmusk T et al Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine. Epilepsia 1996; 37: 198–207.PubMedCrossRefGoogle Scholar
  124. 124.
    Sato K, Kashihara K, Morimoto K et al. Regional increases in brain-derived neurotrophic factor and nerve growth factor mRNAs during amygdaloid kindling, but not in acidic and basic fibroblast growth factor mRNAs. Epilepsia 1996; 37: 6–14.PubMedCrossRefGoogle Scholar
  125. 125.
    Gall CM, Lauterborn JC, Guthrie KM et al. Seizures and the regulation of neurotrophic factor expression: associations with structural plasticity in epilepsy. In: Seil RJ, ed. Advances in Neurology, vol 72: Neuronal Regeneration, Reorganization, and Repair. Philadelphia: Lippincott-Raven, 1997: 9–24.Google Scholar
  126. 126.
    Lowenstein DH, Seren MS, Longo FM. Prolonged increases in neurotrophic activity associated with kainate-induced hippocampal synaptic reorganization. Neuroscience 1993; 56: 597–604.PubMedCrossRefGoogle Scholar
  127. 127.
    Humpel C, Lindqvist E, Soderstrom S et al. Monitoring release of neurotrophic activity in the brains of awake rats. Science 1995; 269: 552–4.PubMedCrossRefGoogle Scholar
  128. 128.
    Nawa H, Carnahan J, Gall C. BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: Partial disagreement with mRNA levels. Eur J Neurosci 1995; 7: 1527–35.PubMedCrossRefGoogle Scholar
  129. 129.
    Elmer E, Kokaia Z, Kokaia M et al. Dynamic changes of brain-derived neurotrophic factor protein levels in the rat forebrain after single and recurring kindling-induced seizures. Neuroscience 1998; 83: 351–62.PubMedCrossRefGoogle Scholar
  130. 130.
    Rudge JS, Mather PE, Pasnikowski EM et al. Endogenous BDNF protein is increased in adult rat hippocampus after a kainic acid induced excitotoxic insult but exogenous BDNF is not neuroprotective. Exp Neurol 1998; 149: 398–410.PubMedCrossRefGoogle Scholar
  131. 131.
    Vezzani A, Ravizza T, Moneta D et al. Brain-derived neurotrophic factor immunoreactivity in the limbic system of rats after acute seizures and during spontaneous convulsions: temporal evolution of changes as compared to neuropeptide Y. Neuroscience 1999; 90: 1445–1461.PubMedCrossRefGoogle Scholar
  132. 132.
    Gall CM, Conner JM, Lauterborn JC et al. Cellular localization of BDNF protein after recurrent seizures in rat: evidence for axonal transport of the newly synthesized factor. Epilepsia 1996; 37 Suppl. 5: 47.Google Scholar
  133. 133.
    Goddard GV. The development of epileptic seizures through brain stimulation at low intensity. Nature 1967; 214: 1020–1021.PubMedCrossRefGoogle Scholar
  134. 134.
    Goddard GV, McIntyre DC, Leech CK. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 1969; 25: 295–330.PubMedCrossRefGoogle Scholar
  135. 135.
    McNamara JO, Bonhaus DW, Shin C. The kindling model of epilepsy. In: Schwartzkroin PA, ed. Epilepsy: Models, mechanisms, and concepts. New York, NY: Cambridge University Press, 1993: 27–47.CrossRefGoogle Scholar
  136. 136.
    Binder DK, McNamara JO. Kindling: a pathologic activity-driven structural and functional plasticity in mature brain. In: Corcoran ME, Moshe S, eds. Kindling 5. New York: Plenum Press, 1997: 245–254.Google Scholar
  137. 137.
    Funabashi T, Sasaki H, Kimura F. Intraventricular injection of antiserum to nerve growth factor delays the development of amygdaloid kindling. Brain Res 1988; 458: 132–6.PubMedCrossRefGoogle Scholar
  138. 138.
    Van der Zee CE, Rashid K, Le K et al. Intraventricular administration of antibodies to nerve growth factor retards kindling and blocks mossy fiber sprouting in adult rats. J Neurosci 1995; 15: 5316–23.PubMedGoogle Scholar
  139. 139.
    Kokaia M, Ernfors P, Kokaia Z et al. Suppressed epileptogenesis in BDNF mutant mice. Exp Neurol 1995; 133: 215–24.PubMedCrossRefGoogle Scholar
  140. 140.
    Croll SD, Suri C, Compton DL et al. Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience 1999; 93: 1491–1506.PubMedCrossRefGoogle Scholar
  141. 141.
    Scharfman HE, Goodman JH, Sollas AL et al. Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor. Exp Neurol 2002; 174: 201–14.PubMedCrossRefGoogle Scholar
  142. 142.
    Binder DK, Routbort MJ, Ryan TE et al. Selective inhibition of kindling development by intraventricular administration of trkB receptor body. J Neurosci 1999; 19: 1424–1436.PubMedGoogle Scholar
  143. 143.
    Larmet Y, Reibel S, Carnahan J et al. Protective effects of brain-derived neurotrophic factor on the development of hippocampal kindling in the rat. Neuroreport 1995; 6: 1937–41.PubMedCrossRefGoogle Scholar
  144. 144.
    Frank L, Ventimiglia R, Anderson K et al. BDNF downregulates neurotrophin responsiveness, trkB protein and trkB mRNA levels in cultured rat hippocampal neurons. Eur J Neurosci 1996; 8: 1220–30.PubMedCrossRefGoogle Scholar
  145. 145.
    Knusel B, Gao H, Okazaki T et al. Ligand-induced down-regulation of trk messenger RNA, protein and tyrosine phosphorylation in rat cortical neurons. Neuroscience 1997; 78: 851–862.PubMedCrossRefGoogle Scholar
  146. 146.
    Lahteinen S, Pitkanen A, Saarelainen T et al. Decreased BDNF signalling in transgenic mice reduces epileptogenesis. Eur J Neurosci 2002; 15: 721–34.PubMedCrossRefGoogle Scholar
  147. 147.
    Binder DK, Routbort MJ, McNamara JO. Immunohistochemical evidence of seizure-induced activation of trk receptors in the mossy fiber pathway of adult rat hippocampus. J Neurosci 1999; 19: 4616–4626.PubMedGoogle Scholar
  148. 148.
    Okazaki MM, Evenson DA, Nadler JV. Hpppocampal mossy fiber sprouting and synapse formation after status epilepticus in rats: Visualization after retrograde transport of biocytin. J Comp Neurol 1995; 352: 515–534.PubMedCrossRefGoogle Scholar
  149. 149.
    Scharfman HE, Goodman JH, Sollas AL. Actions of brain-derived neurotrophic factor in slices from rats with spontaneous seizures and mossy fiber sprouting in the dentate gyrus. J Neurosci 1999; 19: 5619–5631.PubMedGoogle Scholar
  150. 150.
    Wu K, Xu J, Suen P et al. Functional trkB neurotrophin receptors are intrinsic components of the adult brain postsynaptic density. Mol Brain Res 1996; 43: 286–290.PubMedCrossRefGoogle Scholar
  151. 151.
    Drake CT, Milner TA, Patterson SL. Ultrastructural localization of full-length trkB immunoreactivity in rat hippocampus suggests multiple roles in modulating activity-dependent synaptic plasticity. J Neurosci 1999; 19: 8009–26.PubMedGoogle Scholar
  152. 152.
    Kohr G, De Koninck Y, Mody I. Properties of NMDA receptor channels in neurons acutely isolated from epileptic (kindled) rats. J Neurosci 1993; 13: 3612–27.PubMedGoogle Scholar
  153. 153.
    McNamara JO. Cellular and molecular basis of epilepsy. J Neurosci 1994; 14: 3413–3425.PubMedGoogle Scholar
  154. 154.
    Wuarin J-P, Dudek FE. Electrographic seizures and new recurrent excitatory circuits in the dentate gyrus of hippocampal slices from kainate-treated epileptic rats. J Neurosci 1996; 16: 4438–4448.PubMedGoogle Scholar
  155. 155.
    Gibbs JW, Shumate MD, Coulter DA. Differential epilepsy-associated alterations in postsynaptic GABA(A) receptor function in dentate granule and CA1 neurons. J Neurophysiol 1997; 77: 1924–1938.PubMedGoogle Scholar
  156. 156.
    Okazaki MM, Molnar P, Nadler JV. Recurrent mossy fiber pathway in rat dentate gyrus: Synaptic currrents evoked in presence and absence of seizure-induced growth. J Neurophysiol 1999; 81: 1645–1660.PubMedGoogle Scholar
  157. 157.
    Williamson A, Patrylo PR, Spencer DD. Decrease in inhibition in dentate granule cells from patients with medial temporal lobe epilepsy. Ann Neurol 1999; 45: 92–99.PubMedCrossRefGoogle Scholar
  158. 158.
    Behr J, Lyson KJ, Mody I. Enhanced propagation of epileptiform activity through the kindled dentate gyrus. J Neurophysiol 1998; 79: 1726–1732.PubMedGoogle Scholar
  159. 159.
    King GL, Dingledine R, Giacchino JL et al. Abnormal neuronal excitability in hippocampal slices from kindled rats. J Neurophysiol 1985; 54: 1295–304.PubMedGoogle Scholar
  160. 160.
    Buzsaki G, Ponomareff GL, Bayardo F et al. Neuronal activity in the subcortically denervated hippocampus: A chronic model for epilepsy. Neuroscience 1989; 28: 527–538.PubMedCrossRefGoogle Scholar
  161. 161.
    Maccaferri G, Toth K, McBain CJ. Target-specific expression of presynaptic mossy fiber plasticity. Science 1998; 279: 1368–1370.PubMedCrossRefGoogle Scholar
  162. 162.
    Sutula T, He XX, Cavazos J et al. Synaptic reorganization in the hippocampus induced by abnormal functional activity. Science 1988; 239: 1147–50.PubMedCrossRefGoogle Scholar
  163. 163.
    Routbort MJ, Ryan TE, Yancopoulos GD et al. TrkB-IgG does not inhibit mossy fiber sprouting in an in vitro model. Soc Neurosci Abstr 1997; 23: 888.Google Scholar
  164. 164.
    Qiao X, Suri C, Knusel B et al. Absence of hippocampal mossy fiber sprouting in transgenic mice overexpressing brain-derived neurotrophic factor. J Neurosci Res 2001; 64: 268–76.PubMedCrossRefGoogle Scholar
  165. 165.
    Croll SD, Wiegand SJ, Anderson KD et al. Regulation of neuropeptides in adult rat forebrain by the neurotrophins BDNF and NGF. Eur J Neurosci 1994; 6: 1343–53.PubMedCrossRefGoogle Scholar
  166. 166.
    Baraban SC, Hollopeter G, Erickson JC et al. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci 1997; 17: 8927–36.PubMedGoogle Scholar
  167. 167.
    Marksteiner J, Ortler M, Bellmann R et al. Neuropeptide Y biosynthesis is markedly induced in mossy fibers during temporal lobe epilepsy of the rat. Neurosci Lett 1990; 112: 143–148.PubMedCrossRefGoogle Scholar
  168. 168.
    Mathern GW, Babb TL, Micevych PE et al. Granule cell mRNA levels for BDNF, NGF, and NT-3 correlate with neuron losses or supragranular mossy fiber sprouting in the chronically damaged and epileptic human hippocampus. Mol Chem Neuropathol 1997; 30: 53–76.PubMedCrossRefGoogle Scholar
  169. 169.
    Murray KD, Isackson PJ, Eskin TA et al. Altered mRNA expression for brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase in the hippocampus of patients with intractable temporal lobe epilepsy. J Comp Neurol 2000; 418: 411–22.PubMedCrossRefGoogle Scholar
  170. 170.
    Takahashi M, Hayashi S, Kakita A et al. Patients with temporal lobe epilepsy show an increase in brain-derived neurotrophic factor protein and its correlation with neuropeptide Y. Brain Res 1999; 818: 579–82.PubMedCrossRefGoogle Scholar
  171. 171.
    Zhu WJ, Roper SN. Brain-derived neurotrophic factor enhances fast excitatory synaptic transmission in human epileptic dentate gyrus. Ann Neurol 2001; 50: 188–94.PubMedCrossRefGoogle Scholar
  172. 172.
    Villemure JG, de Tribolet N. Epilepsy in patients with central nervous system tumors. Curr Opin Neurol 1996; 9: 424–8.PubMedCrossRefGoogle Scholar
  173. 173.
    Monica E, Leenstra S, Jansen GH et al. Expression of brain-derived neurotrophic factor and tyrosine kinase B receptor proteins in glioneuronal tumors from patients with intractable epilepsy: colocalization with N-methyl-D-aspartic acid receptor. Acta Neuropathol (Berl) 2001; 101: 383–392.Google Scholar
  174. 174.
    Murer MG, Yan Q, Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease. Prog Neurobiol 2001; 63: 71–124.PubMedCrossRefGoogle Scholar
  175. 175.
    Zuccato C, Ciammola A, Rigamonti D et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington’s disease. Science 2001; 293: 493–498.PubMedCrossRefGoogle Scholar
  176. 176.
    Bennett DL. Neurotrophic factors: Important regulators of nociceptive function. Neuroscientist 2001; 7: 13–17.PubMedCrossRefGoogle Scholar
  177. 177.
    Thompson SW, Bennett DL, Kerr BJ et al. Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proc Natl Acad Sci USA 1999; 96: 7714–7718.PubMedCrossRefGoogle Scholar
  178. 178.
    Zhou X-F, Parada LF, Soppet D et al. Distribution of trkB tyrosine kinase immunoreactivity in the rat central nervous system. Brain Res 1993; 622: 63–70.PubMedCrossRefGoogle Scholar
  179. 179.
    Shu XQ, Mendell LM. Neurotrophins and hyperalgesia. Proc Natl Acad Sci USA 1999; 96: 7693–7696.PubMedCrossRefGoogle Scholar
  180. 180.
    Woolf CJ, Thompson SWN. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 293–299.PubMedCrossRefGoogle Scholar
  181. 181.
    Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000; 288: 1765–9.PubMedCrossRefGoogle Scholar
  182. 182.
    Milian MJ. The induction of pain: an integrative review. Prog Neurobiol 1999; 57: 1–164.CrossRefGoogle Scholar
  183. 183.
    Cho HJ, Kim JK, Zhou XF et al. Increased brain-derived neurotrophic factor immunoreactivity in rat dorsal root ganglia and spinal cord following peripheral inflammation. Brain Res 1997; 764: 269–72.PubMedCrossRefGoogle Scholar
  184. 184.
    Oyelese AA, Rizzo MA, Waxman SG et al. Differential effects of NGF and BDNF on axotomy-induced changes in GABA(A)-receptor-mediated conductance and sodium currents in cutaneous afferent neurons. J Neurophysiol 1997; 78: 31–42.PubMedGoogle Scholar
  185. 185.
    Mannion RJ, Costigan M, Decosterd I et al. Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity. Proc Natl Acad Sci USA 1999; 96: 9385–90.PubMedCrossRefGoogle Scholar
  186. 186.
    McMahon SB, Bennett DL, Priestley JV et al. The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nat Med 1995; 1: 774–80.PubMedCrossRefGoogle Scholar
  187. 187.
    Dmitrieva N, Shelton D, Rice ASC et al. The role of nerve growth factor in a model of visceral inflammation. Neuroscience 1997; 78: 449–459.PubMedCrossRefGoogle Scholar
  188. 188.
    Ma QP, Woolf CJ. The progressive tactile hyperalgesia induced by peripheral inflammation is nerve growth factor dependent. Neuroreport 1997; 8: 807–810.PubMedCrossRefGoogle Scholar
  189. 189.
    Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science 1997; 278: 58–63.PubMedCrossRefGoogle Scholar
  190. 190.
    Meredith G, Callen S, Scheuer D. Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration. Brain Res 2002; 949: 218.PubMedCrossRefGoogle Scholar
  191. 191.
    Numan S, Lane-Ladd SB, Zhang L et al. Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal. J Neurosci 1998; 18: 10700–8.PubMedGoogle Scholar
  192. 192.
    Akbarian S, Rios M, Liu RJ et al. Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons. J Neurosci 2002; 22: 4153–62.PubMedGoogle Scholar
  193. 193.
    Le Foll B, Schwartz JC, Sokoloff P. Dopamine D3 receptor agents as potential new medications for drug addiction. Eur Psychiatry 2000; 15: 140–6.PubMedCrossRefGoogle Scholar
  194. 194.
    Guillin O, Diaz J, Carroll P et al. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 2001; 411: 86–89.PubMedCrossRefGoogle Scholar
  195. 195.
    Altar CA. Neurotrophins and depression. Trends Pharmacol Sci 1999; 20: 59–61.PubMedCrossRefGoogle Scholar
  196. 196.
    Nestler EJ, Barrot M, DiLeone RJ et al. Neurobiology of depression. Neuron 2002; 34: 13–25.PubMedCrossRefGoogle Scholar
  197. 197.
    Alleva E, Santucci D. Psychosocial vs. “physical” stress situations in rodents and humans: role of neurotrophins. Physiol Behav 2001; 73: 313–20.PubMedCrossRefGoogle Scholar
  198. 198.
    Neves-Pereira M, Mundo E, Muglia P et al. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002; 71: 651–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Devin K. Binder

There are no affiliations available

Personalised recommendations